Evaluation of the Efficacy and Safety of Rupatadine & Loratadine in Chronic Idiopathic Urticaria - A Randomized Single-Blind Comparative Clinical Study

SRM University0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Man or woman aged between 18 to 65yrs old.
•2.Documented history of active CIU (urticaria wheals) for at least three days per week over the last 6 weeks.
•3.Active CIU(labeled as moderate pruritus) for at least 3 days (not necessarily consecutive days) in the week before inclusion with a total score of active CIU labeled as at least a moderate severity of pruritus (score>=2) for these 3 days.
•4.Those who were willing to participate in the study and comply with its procedures by signing a written informed consent.

•1.Patients suffering from other forms of urticaria, with significant concomitant illness (e.g., malignancies or hepatic, psychiatric, endocrine or other major systemic diseases).
•2.Pregnant women, lactating mothers, females on oral contraceptive pills.
•3.Patients on antihistaminic therapy for 72 hours, or steroids for one
•month, were excluded from the study.
•4.Patients with Drug Allergy.

发起方